Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

42.16
Delayed Data
As of 3:59pm ET
 -0.17 / -0.40%
Today’s Change
33.60
Today|||52-Week Range
50.40
+10.51%
Year-to-Date
Mylan (MYL) to Post Q4 Earnings: Will the Stock Disappoint?
4:58pm / Zacks.com - Paid Partner Content
Where Are the Best Buying Opportunities in Stocks Right Now?
Feb 21 / Zacks.com - Paid Partner Content
Fore Research & Management, LP Buys CA, Vodafone Group PLC, LiLAC Group, Sells Centra...
Feb 23 / GuruFocus News - Paid Partner Content
Mylan's Proposed Biosimailar for Cancer Under Review in U.S.
Feb 17 / Zacks.com - Paid Partner Content
North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Communi...
Feb 22 / GuruFocus News - Paid Partner Content
Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
Feb 16 / MotleyFool.com - Paid Partner Content
Momenta Pharmaceuticals, Inc. Earnings Take a Back Seat
Feb 22 / MotleyFool.com - Paid Partner Content
Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance
Feb 14 / Zacks.com - Paid Partner Content
Drug Addiction Treatment Stocks to Watch
Feb 22 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close42.33
Today’s open42.12
Day’s range41.76 - 42.35
Volume4,857,746
Average volume (3 months)5,697,334
Market cap$22.7B
Dividend yield--
Data as of 3:59pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+10.25%
Earnings growth (next 5 years)+7.25%
Revenue growth (last year)+21.91%
P/E ratio18.2
Price/Sales2.84
Price/Book2.13

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+9.26+7.59%
VRTXVertex Pharmaceutica...+0.34+0.40%
ZTSZoetis Inc+0.30+0.56%
BAXBaxter International...+0.10+0.20%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$1.42
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts


Search for Jobs